Alpha Cognition (ACOG) Revenue (2025)

Alpha Cognition's (ACOG) quarterly Revenue came in at $2.8 million in Q4 2025, down 1.68% quarter-over-quarter from $2.8 million in Q3 2025.

Alpha Cognition (ACOG) Revenue (2025) Analysis & Trends

Alpha Cognition's Revenue history runs 1 years deep, the most recent figure standing at $2.8 million for Q4 2025.

On a quarterly basis, Revenue changed N/A year-over-year to $2.8 million in Q4 2025; TTM through Dec 2025 was $10.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $10.2 million, changed N/A from the prior year.
Revenue fell to $2.8 million in Q4 2025 per ACOG's latest filing, from $2.8 million in the prior quarter.
Across five years, Revenue topped out at $2.9 million in Q1 2025 and bottomed at $1.7 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Revenue (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	1.51 Bn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	2.99 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	3.61 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	1.56 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Alpha Cognition	145.51 Mn	79.41 Mn	2.61 Mn	2.79 Mn

Download Data